Quince Therapeutics, Inc.
QNCX
$32.40+2.11%
End of day · as of Oct 13, 2026, 3:30 AM ET
Mkt cap
$79.25M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-12.01
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.80
Div yield
N/A
Sector
Healthcare
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Use this QNCX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full QNCX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Quince Therapeutics, Inc. (QNCX) is a biotechnology company in the Healthcare sector.
Latest cached Quince Therapeutics, Inc. (QNCX) net income for FY2025 was -$84.0M. Statements: https://lician.com/financials/qncx
Quince Therapeutics, Inc. (QNCX) market capitalization is $79.3M on the latest cached snapshot.
Quince Therapeutics, Inc. (QNCX) cached previous close $31.73; day range $26.50 – $32.61; volume 76,900. Session quote: https://lician.com/quote/qncx
Quince Therapeutics, Inc. (QNCX) latest cached earnings event is "QNCX earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached QNCX filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/qncx